Ramosetron: International drug information (concise)

For abbreviations, symbols, and age group definitions show table

International Brand Names

International Brand Names by Country

For country code abbreviations (show table)

(CN) China: Nasea;
(ID) Indonesia: Nasea | Ramozea;
(IN) India: Ibset | Nozia | Ramobliss;
(JP) Japan: Irribow | Nasea | Nasea od | Ramosetron HCL | Ramosetron Hcl Sandoz;
(KR) Korea, Republic of: Emestop | Emestop FDT | Irribow | Irricol | Nasea | Nasea od | Naseron | Naseron od | Ramea | Ramo one | Ramob | Ramocan | Ramoset | Ramozea | Ramset | Ramtron;
(PH) Philippines: Nasea;
(TH) Thailand: Irribow | Nasea;
(TW) Taiwan: Setoral

Index Terms

Pharmacologic Category

Reported Use

Prevention of chemotherapy-induced or postoperative nausea and vomiting; treatment of irritable bowel syndrome with diarrhea

Dosage Range

Adults:

Irritable bowel syndrome with diarrhea: Oral (tablet):

Females: 2.5 to 5 mcg once daily (maximum: 5 mcg/day).

Males: 2.5 to 10 mcg once daily (maximum: 10 mcg/day).

Prevention of chemotherapy-induced nausea and vomiting:

Oral (orally disintegrating tablet): 100 mcg once daily administered 1 hour prior to chemotherapy.

IV: 300 to 600 mcg once daily (maximum: 600 mcg/day).

Prevention of postoperative nausea and/or vomiting: IV: 300 to 600 mcg once daily (maximum: 600 mcg/day).

Product Availability

Product available in various countries; not currently available in the US

Dosage Forms

Solution, Intravenous: 300 mcg/2 mL (2 mL)

Tablet, Oral: 2.5 mcg, 5 mcg

Tablet Dispersable, Oral: 100 mcg

Topic 10501 Version 50.0